According to DelveInsight's' estimates, the adrenocortical carcinoma market in 7MM is expected to show positive growth, during the forecast period (2024-2034), mainly attributed to the anticipated
Hepatocellular Carcinoma Clinical Trial Pipeline Insights | 90+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
Research and Markets: Hepatocellular Carcinoma Epidemiology Forecast to 2029: Focus on US, France, Germany, Italy, Spain, UK, Japan, and Urban China - ResearchAndMarkets.com
ResearchAndMarkets.com s offering.
The Hepatocellular Carcinoma (HCC) Epidemiology Report provides an overview of the risk factors and the global and historical trends for HCC in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China). The report includes the diagnosed incident cases and five-year diagnosed prevalent cases of HCC in these markets from 2019-2029.
Hepatocellular carcinoma (HCC) is a common type of primary liver cancer that arises from the hepatocytes in the liver. HCC has a high mortality rate and accounts for 75-90% of all primary liver cancers, making it the third leading cause of cancer mortality worldwide (El-Serag and Rudolph, 2007; Altekruse, McGlynn and Reichman, 2009; Lafaro, Demirjian and Pawlik, 2015; Cancer Treatment Centers of America, 2020). HC